Search results
... Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory ...
Morningstar· 3 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B< ...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 1 day agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory ...
EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL
Pharmaceutical Technology via Yahoo Finance· 2 days agoBased on the latest STARGLO trial results, there is potential to extend Columvi into earlier lines...
Atezolizumab Consolidation Impresses in High-Risk DLBCL
MedPage Today· 4 days agoPostchemotherapy consolidation with atezolizumab (Tecentriq) led to a surprisingly high 2-year...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 hours agoNEWSPLUS The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0235...
Roche’s Columvi offers extended survival in Phase III DLBCL trial
Clinical Trials Arena via Yahoo Finance· 1 day agoRoche has reported findings from the Phase III STARGLO clinical trial where Columvi, in combination...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoIn one study, Pfizer's Seagen-acquired drug, Adcetris, reduced the risk of death by 37% for patients...
Roche shares hold as analyst backs Buy rating By Investing.com
Investing.com· 1 day agoThe data presented was the first of its kind for one of Roche's CD20 bispecifics, indicating a...
Three-Drug Regimen Shows OS Benefit in Third-Line DLBCL
MedPage Today· 1 day agoLoretta Nastoupil, MD, leads a discussion on the ECHELON-3 trial results
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 6 days agoThe T-cell lymphoma occurred in a patient who received CAR T-cell therapy for a diffuse large B-cell...